ArticleCells2021

EGFR-D770>GY and Other Rare EGFR Exon 20 Insertion Mutations with a G770 Equivalence Are Sensitive to Dacomitinib or Afatinib and Responsive to EGFR Exon 20 Insertion Mutant-Active Inhibitors in Preclinical Models and Clinical Scenarios.

Ikei S Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.